Navigation Links
2013 Wiley Prize to be awarded at Apr. 5 event
Date:3/29/2013

Hoboken, N.J. March 28, 2013 - Deborah E. Wiley, Chair of The Wiley Foundation, John Wiley & Sons, Inc. (NYSE: JWa & JWb) will present the 2013 Wiley Prize in Biomedical Sciences to Dr. Michael Young, Rockefeller University, Dr. Jeffrey Hall, Brandeis University (Emeritus), and Dr. Michael Rosbash, Brandeis University on Friday April 5.

The ceremony will take place at Caspary Auditorium, The Rockefeller University, 1230 York Avenue, New York, New York at 4:00 p.m. After receiving the award the three men will each present a brief lecture relating to their discovery of the molecular mechanisms governing circadian rhythms. The lecture will be streaming live here.

Studies of the molecular basis for circadian rhythmicity began more than thirty years ago in the lab of Dr. Young at Rockefeller University and Drs. Hall and Rosbash at Brandeis. Over the past three decades, the work of the three men focused on the fruitfly Drosophila melanogaster, with their research showing that the fly's circadian clocks are formed through the actions of a small group of genes.

These discoveries also apply to humans and other mammals, and could ultimately lead to the development of drugs to treat sleep disorders and jet lag, plus conditions associated with employees who work non-traditional shifts.

There is also evidence that the effectiveness of many drugs (including chemotherapeutics), our ability to fight infection, our ability to repair damaged tissues, and the incidence of certain forms of cancer depend on the proper working of circadian clocks. The Wiley Prize in Biomedical Sciences recognizes a specific contribution or series of contributions that demonstrate significant leadership in the development of research concepts or their clinical application. Particular emphasis is placed on research that champions novel approaches and challenges accepted thinking in the biomedical sciences.

The Wiley Foundation and the Wiley Prize in Biomedical Sciences were established in 2001.


'/>"/>

Contact: Peter Peretzman
sciencenewsroom@wiley.com
201-748-6098
Wiley
Source:Eurekalert

Related biology news :

1. The Scandinavian Plant Physiology Society and Wiley extend over 60 years of partnership
2. 66 titles join Wileys journal portfolio in 2013
3. Over 12,000 Wiley Online Books made available in developing countries via Research4Life
4. Wiley makes scientific PDFs interactive with the ReadCube Web Reader from Labtiva
5. 12th annual Wiley Prize in Biomedical Sciences awarded
6. Wiley Prize in Biomedical Sciences awarded to Rosbash, Hall and Young
7. Physiological societies partner with Wiley on new open access journal
8. Wiley Partners with TED
9. British Ecological Society partners with Wiley open access journal Ecology and Evolution
10. Wiley signs collaboration agreement with the Asian Federation of Biotechnology
11. Wiley launches new interdisciplinary review WIREs Energy and Environment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... --  Strategic Cyber Ventures , the industry,s first cybersecurity ... million investment in  Polarity , the first commercial human ... based and is led by cybersecurity veterans Tom ... Gula , also a longtime cybersecurity veteran and founder ... A round of funding. This new funding will be ...
(Date:2/21/2017)... Der weltweite Biobanking-Sektor wird bis ... Gespräch mit mehr als 50 Vertretern aus verschiedenen Branchen wurde ... um diese Prognose zu realisieren. ... Zu den Schwierigkeiten ... Mittel für die Biobank, die Implementierung Zeit sparender Technologien, ...
(Date:2/10/2017)... Research and Markets has announced the addition of ... Commercial Aspects" to their offering. ... Biomarkers play an important ... selection of treatment as well for monitoring the results. There ... modern medicine. Biochip/microarray technologies and next generation sequencing are also ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... 23, 2017  GlobeImmune, Inc. today announced it has ... of 12,835,490 shares of its common stock to NantCell, ... connection with the sale of its common stock, NantCell ... issue to GlobeImmune 200,000 shares, an estimated $2.0 million ... "We are pleased to enter into this strategic agreement ...
(Date:3/23/2017)... March 23, 2017 NetworkNewsWire Editorial Coverage  ... Cancer ... significant strain on health care systems, in terms of costs ... so too does the development of innovative and efficient therapies ... Among the many types of cancer treatments, a growing number ...
(Date:3/23/2017)... ... March 23, 2017 , ... Advanced Polymer Monitoring Technologies ... Dr. Sigmund “Sig” Floyd as Vice President ? Global Business Development. Dr. Floyd ... , “Dr. Floyd’s career has spanned 30 years in the chemicals and equipment ...
(Date:3/22/2017)... 2017  UBM and the Massachusetts Medical Device ... partnership and the third annual Massachusetts Medtech Week. Massachusetts ... st Annual MassMEDIC Conference held in conjunction ... 2017. MassMEDIC will feature a ... and CEO, Scott Whitaker , at its ...
Breaking Biology Technology: